Amgen Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $26.95B | $9.67B | $6.04B |
| FY2020 | $32.90B | $9.41B | $6.27B |
| FY2021 | $33.22B | $6.70B | $7.99B |
| FY2022 | $37.35B | $3.66B | $7.63B |
| FY2023 | $63.17B | $6.23B | $10.94B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2019 | $26.95B | $9.67B | $6.04B |
| FY2020 | $32.90B | $9.41B | $6.27B |
| FY2021 | $33.22B | $6.70B | $7.99B |
| FY2022 | $37.35B | $3.66B | $7.63B |
| FY2023 | $63.17B | $6.23B | $10.94B |